Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C

Digestive Diseases and Sciences

Volumn 52, Issue 6, 2007, Pages 1535-1539

  Karasu, Zeki ^a,b   Tekin, Fatih ^a   Ersoz, Galip ^a   Gunsar, Fulya ^a   Batur, Yucel ^a   Ilter, Tankut ^a   Akarca, Ulus S ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Ege Üniversites I Tip Fakültesi   (Turkey)

Author keywords

Chronic viral hepatitis; Fibrosis; Platelet count

Indexed keywords

ADULT; ARTICLE; CHRONIC HEPATITIS; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENDER; GROUPS BY AGE; HEPATITIS B; HEPATITIS C; HUMAN; HYPERSPLENISM; LIVER FIBROSIS; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PANCYTOPENIA; PRIORITY JOURNAL; SCORING SYSTEM; SPLENOMEGALY; THROMBOCYTE COUNT; UNIVARIATE ANALYSIS; VIRUS HEPATITIS;

ADULT; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; RETROSPECTIVE STUDIES;

EID: 34248649581     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9144-y     Document Type: Article

References (44)

1. Morlock CG, Hall BE (1943) Association of cirrhosis, thrombocytopenia and hemorrhagic tendency. Arch Intern Med 72:69-77
2. Felix WR Jr, Myerson RM, Sigel B, Perrin EB, Jackson FC (1974) The effect of portacaval shunt on hypersplenism. Surg Gynecol Obstet 139:899-903
3. Soper NJ, Rikkers LF (1982) Effect of operations for variceal hemorrhage on hypersplenism. Am J Surg 144:70
4. Morris PW, Patton TB, Balint JA, Hirschowitz BI (1962) Portal hypertension, congestive splenomegaly, and portacaval shunt. Gastroenterology 42:555-559
5. Mutchnick MG, Lerner E, Conn HO (1980) Effect of portacaval anastamosis on hypersplenism. Dig Dis Sci 25:929-938
6. Hutson DG, Zeppa R, Levi JU, Schiff ER, Livingstone AS, Fink P (1977) The effect of the distal splenorenal shunt on hypersplenism. Ann Surg 185:605-612
7. Frick V (1967) Thrombocytopenie und lebercirrhose. Scweiz Med Wochens 97:407-413
8. Fiore LD, Brophy MT, Deykin D (2003) Hemostasis. In: Zackim D, Boyer TD (eds) Hepatology: A textbook of liver disease. 4th edn. pp 562-563
9. Omata M (1998) Screening for hepatocellular carcinoma. In: Advances in therapeutic hepatology: A word view. Postgraduate course book. University of Chicago Press, Chicago, pp. 49-53
10. Moschcowitz E (1948) The pathogenesis of splenomegaly in hypertension of the portal circulation: "congestive splenomegaly." Medicine 27:187-221
11. Landolfi R, Leone G, Fedeli G, Storti S, Laghi F, Bizzi B (1980) Platelet-associated IgG in acute and chronic hepatic diseases. Scand J Haematol 25:417-422
12. de Noronha R, Taylor BA, Wild G, Triger DR, Greaves M (1991) Interrelationships between platelet count, platelet IgG, serum IgG, immune-complexes and severity of liver disease. Clin Lab Haematol 13:127-135
13. Skootsky SA, Rosove MH, Langley MB (1986) Immune thrombocytopenia and response to splenectomy in chronic liver disease. Arch Intern Med 146:555-557
14. Paramo JA, Rocha E (1993) Hemostasis in advanced liver disease. Semin Thromb Hemost 19:184-190
15. Wehmeier A, Scharf RE, Schneider W (1990) Influence of splenectomy on platelet morphometry and function. Klin Wochenschr 68:847-852
16. Thomas HC, McSween RN, White RG (1973) Role of the liver in controlling the immunogenicity of commensal bacteria in the gut. Lancet 1:1288-1291
17. Triger DR, Wright R (1973) Hyperglobulinaemia in liver disease. Lancet 1:1494-1496
18. Kew MC (1996) Hepatitis B and C viruses and hepatocellular carcinoma. Clin Lab Med 16:395-406
19. MacPherson AI, Innes J (1953) Peripheral blood picture after operation for portal hypertension. Lancet 1:1120-1123
20. Vang J, Simert G, Hansson JA, Thylen U, Bengmark TS (1977) Results of a modified distal spleno-renal shunt for portal hypertension. Ann Surg 185:224-228
21. Sullivan BH Jr, Tumen HJ (1961) The effect of portacaval shunt on thrombocytopenia associated with portal hypertension. Ann Intern Med 55:598-603
22. Karasu Z, Gurakar A, Kerwin B, Hulagu S, Jazzar A, McFadden R, Nour B, Sebastian A, Cassidy F, Stokes K, Van Thiel DH, Wright H (2000) Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis. Dig Dis Sci 45:1971-1976.
23. Patton TB, Johnston CG, Lyons C, Jordan P Jr (1959) Lateral portacaval anastomosis for portal hypertension: long term results in 58 patients with intrahepatic portal bed block and 7 patients with extrahepatic portal bed block. Am J Gastroenterol 32:291-310
24. Puttini M, Marni A, Montes F, Belli L (1979) Effect of portasystemic shunt on hypersplenism: Clinical study in 129 patients with cirrhosis. Am Surg 45:444-448
25. Ferrara J, Ellison EC, Martin EW Jr, Cooperman M (1979) Correction of hypersplenism following distal splenorenal shunt. Surgery 86:570-573
26. Malt RA (1976) Portasystemic venous shunts (part 1). N Engl J Med 295:24-29
27. Marni A, Trojsi C, Belli L (1981) Distal splenorenal shunt. Hemodynamic advantage over total shunt and influence on clinical status, hepatic function and hypersplenism. Am J Surg 142:372-376
28. LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, Ascher NL (1993) Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology 187:413-420
29. Lawrence SP, Lezotte DC, Durham JD, Kumpe DA, Everson GT, Bilir BM (1995) Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis. Dig Dis Sci 40:1575-1580
30. Alvarez OA, Lopera GA, Patel V, Encarnacion CE, Palmaz JC, Lee M (1996) Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients. Am J Gastroenterol 91:134-137
31. Sungaran R, Markovic B, Chong BH (1997) Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow and spleen using in situ hybridization. Blood 89:101-107
32. Martin TG 3rd, Somberg KA, Meng YG, Cohen RL, Heid CA, de Sauvage FJ, Shuman MA (1997) Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 127:285-288
33. Peck-Radosavljevic M, Zacherl J, Meng YG, Pidlich J, Lipinski E, Langle F, Steininger R, Muhlbacher F, Gangl A (1997) Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol 27:127-131
34. Ishikawa T, Ichida T, Matsuda Y, Sugitani S, Sugiyama M, Kato T, Miyazaki H, Asakura H (1998) Reduced expression of thrombopoietin is involved in thrombocytopenia in human and rat liver cirrhosis. J Gastroenterol Hepatol 13:907-913
35. Stiegler G, Stohlawetz P, Peck-Radosavljevic M, Jilma B, Pidlich J, Wichlas M, Hocker P, Panzer S (1998) Direct evidence for an increase in thrombopoiesis after liver transplantation. Eur J Clin Invest 28:755-759
36. Yanaga K, Tzakis AG, Shimada M, Campbell WE, Marsh JW, Stieber AC, Makowka L, Todo S, Gordon RD, Iwatsuki S (1989) Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg 210:180-183
37. Hutchison DE, Genton E, Porter KA, Daloze PM, Huguet C, Brettschneider L, Groth CG, Starzl TE (1968) Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg 97:27-33
38. Rinkes IH, Van der Hoop AG, Hesselink EJ, Metselaar H, De Rave S, Zonderland HM, Schalm SW, Terpstra OT (1991) Does auxiliary heterotopic liver transplantation reverse hypersplenism and portal hypertension? Gastroenterology 100:1126-1128
39. Ono E, Shiratori Y, Okudaira T, Imamura M, Teratani T, Kanai F, Kato N, Yoshida Y, Shiina S, Omata M (1999) Platelet count reflects stage of chronic hepatitis C. Hepatol Res 15:192-200
40. Matsumuro H, Moriyama M, Goto I, Tanaka N, Okubo H, Arakawa Y (2000) Natural course of progression of liver fibrosis in Japanese patients with chronic liver disease type C-a study of 527 patients at one establishment. J Viral Hepat 7:268-275
41. Okubo M, Shiota G, Kawasaki H (2000) Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma. Clin Sci (Lond) 99:207-214
42. Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T (2001) Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol 96:3142-3146
43. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435
44. Fusegawa H, Shiraishi K, Ogasawara F, Shimizu M, Haruki Y, Miyachi H, Matsuzaki S, Ando Y (2002) Platelet activation in patients with chronic hepatitis C. Tokai J Exp Clin Med 27:101-106